• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relation of Myocardial Perfusion Reserve and Left Ventricular Ejection Fraction in Ischemic and Nonischemic Cardiomyopathy.缺血性和非缺血性心肌病的心肌灌注储备与左心室射血分数的关系。
Am J Cardiol. 2022 Jul 1;174:143-150. doi: 10.1016/j.amjcard.2022.02.022. Epub 2022 Apr 26.
2
Developing and evaluating a chronic ischemic cardiomyopathy in swine model by rest and stress CMR.通过静息和负荷心脏磁共振成像在猪模型中建立和评估慢性缺血性心肌病
Int J Cardiovasc Imaging. 2024 Feb;40(2):249-260. doi: 10.1007/s10554-023-02999-4. Epub 2023 Nov 16.
3
Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome.弗里德里希共济失调患者的心肌血流储备和纤维化:一种具有代谢综合征的线粒体心肌病。
Eur Heart J. 2011 Mar;32(5):561-7. doi: 10.1093/eurheartj/ehq443. Epub 2010 Dec 14.
4
Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson.考虑使用雷卡地诺生测量心血管磁共振心肌灌注储备时的注意事项。
J Cardiovasc Magn Reson. 2012 Dec 28;14(1):89. doi: 10.1186/1532-429X-14-89.
5
Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.心肌灌注储备和整体纵向应变作为晚期原位心脏移植中冠状动脉移植血管病的潜在标志物。
Int J Cardiovasc Imaging. 2018 Oct;34(10):1607-1617. doi: 10.1007/s10554-018-1364-7. Epub 2018 May 4.
6
Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.心力衰竭伴左心室射血分数保留患者的冠状动脉微血管功能障碍和弥漫性心肌纤维化(心血管磁共振测量)的频率。
Am J Cardiol. 2019 Nov 15;124(10):1584-1589. doi: 10.1016/j.amjcard.2019.08.011. Epub 2019 Aug 22.
7
Native Myocardial T1 as a Biomarker of Cardiac Structure in Non-Ischemic Cardiomyopathy.天然心肌T1作为非缺血性心肌病心脏结构的生物标志物。
Am J Cardiol. 2016 Jan 15;117(2):282-8. doi: 10.1016/j.amjcard.2015.10.046. Epub 2015 Nov 6.
8
Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.CMR 基于速度编码冠状动脉窦流量测量和首过灌注成像评估的 DCM 和 HCM 患者的心肌灌注储备降低。
Clin Res Cardiol. 2018 Nov;107(11):1062-1070. doi: 10.1007/s00392-018-1279-2. Epub 2018 May 17.
9
Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction.心血管磁共振成像中的心肌灌注储备:与冠状动脉微血管功能障碍的相关性。
J Cardiovasc Magn Reson. 2006;8(6):781-7. doi: 10.1080/10976640600737649.
10
Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonance.利用心血管磁共振显示非缺血性心肌病中定量微血管功能障碍。
PLoS One. 2022 Nov 18;17(11):e0264454. doi: 10.1371/journal.pone.0264454. eCollection 2022.

引用本文的文献

1
Recent Progress of Cardiac MRI for Nuclear Medicine Professionals.核医学专业人员的心脏磁共振成像最新进展
Nucl Med Mol Imaging. 2024 Dec;58(7):431-448. doi: 10.1007/s13139-024-00850-9. Epub 2024 Feb 14.

本文引用的文献

1
Impairment in quantitative microvascular function in non-ischemic cardiomyopathy as demonstrated using cardiovascular magnetic resonance.利用心血管磁共振显示非缺血性心肌病中定量微血管功能障碍。
PLoS One. 2022 Nov 18;17(11):e0264454. doi: 10.1371/journal.pone.0264454. eCollection 2022.
2
Stress Cardiac Magnetic Resonance Myocardial Perfusion Imaging: JACC Review Topic of the Week.压力心脏磁共振心肌灌注成像:JACC 每周综述专题。
J Am Coll Cardiol. 2021 Oct 19;78(16):1655-1668. doi: 10.1016/j.jacc.2021.08.022.
3
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.基于冠状动脉疾病和缺血严重程度的 ISCHEMIA 试验结果。
Circulation. 2021 Sep 28;144(13):1024-1038. doi: 10.1161/CIRCULATIONAHA.120.049755. Epub 2021 Sep 9.
4
Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance.应用应激灌注心脏磁共振评估冠状动脉微血管疾病患者的长期预后。
JACC Cardiovasc Imaging. 2021 Mar;14(3):602-611. doi: 10.1016/j.jcmg.2020.09.034. Epub 2020 Nov 25.
5
Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial.稳定性缺血性心脏病患者有心力衰竭或左心室功能障碍病史时的初始侵入性与保守性管理:来自 ISCHEMIA 试验的见解。
Circulation. 2020 Nov 3;142(18):1725-1735. doi: 10.1161/CIRCULATIONAHA.120.050304. Epub 2020 Aug 29.
6
Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function.左心室收缩功能降低患者的应激 CMR 灌注成像的预后价值。
JACC Cardiovasc Imaging. 2020 Oct;13(10):2132-2145. doi: 10.1016/j.jcmg.2020.05.034. Epub 2020 Aug 5.
7
Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity.冠状动脉痉挛:内皮功能障碍与血管平滑肌细胞高反应性之间的相互作用
Eur Cardiol. 2020 Apr 6;15:e12. doi: 10.15420/ecr.2019.20. eCollection 2020 Feb.
8
Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update : Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing.心血管磁共振标准化图像解读和后处理 - 2020 年更新:心血管磁共振学会(SCMR):标准化后处理董事会信托基金工作组。
J Cardiovasc Magn Reson. 2020 Mar 12;22(1):19. doi: 10.1186/s12968-020-00610-6.
9
Microvascular Dysfunction in Dilated Cardiomyopathy: A Quantitative Stress Perfusion Cardiovascular Magnetic Resonance Study.扩张型心肌病的微血管功能障碍:一项定量应激灌注心血管磁共振研究。
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1699-1708. doi: 10.1016/j.jcmg.2018.10.032. Epub 2019 Jan 16.
10
Absolute Myocardial Blood Flow in Dilated Cardiomyopathy: Does it Matter?扩张型心肌病中的绝对心肌血流量:这重要吗?
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1709-1711. doi: 10.1016/j.jcmg.2018.12.002. Epub 2019 Jan 16.

缺血性和非缺血性心肌病的心肌灌注储备与左心室射血分数的关系。

Relation of Myocardial Perfusion Reserve and Left Ventricular Ejection Fraction in Ischemic and Nonischemic Cardiomyopathy.

机构信息

Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China; Department of Medicine, University of Chicago, Chicago, Illinois.

Department of Medicine, University of Chicago, Chicago, Illinois.

出版信息

Am J Cardiol. 2022 Jul 1;174:143-150. doi: 10.1016/j.amjcard.2022.02.022. Epub 2022 Apr 26.

DOI:10.1016/j.amjcard.2022.02.022
PMID:35487776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9886436/
Abstract

Quantification of myocardial perfusion reserve (MPR) using vasodilator stress cardiac magnetic resonance is increasingly used to detect coronary artery disease. However, MPR can also be altered because of changes in microvascular function. We aimed to determine whether MPR can distinguish between ischemic cardiomyopathy (IC) secondary to coronary artery disease and non-IC (NIC) with microvascular dysfunction and no underlying epicardial coronary disease. A total of 60 patients (mean age 65 ± 14 years, 30% women), including 31 with IC and 29 with NIC, were identified from a pre-existing vasodilator stress cardiac magnetic resonance registry. Short-axis cine slices were used to measure left ventricular ejection fraction (LVEF) using the Simpson method of disks. MPR index (MPRi) was determined from first-pass myocardial perfusion images during stress and rest using the upslope ratio, normalized for the arterial input and corrected for rate pressure product. Patients in both groups were divided into subgroups of LVEF ≤35% and LVEF >35%. Differences in MPRi between the subgroups were examined. MPRi was moderately correlated with LVEF in patients with NIC (r = 0.53, p = 0.03), whereas the correlation in patients with IC was lower (r = 0.32, p = 0.22). Average LVEF in NIC and IC was 34% ± 8% and 35% ± 8%, respectively (p = 0.63). MPRi was not significantly different in IC compared with NIC (1.17 [0.88 to 1.61] vs 1.23 [1.07 to 1.66], p = 0.41), including the subgroups of LVEF (IC: 1.20 ± 0.56 vs NIC: 1.15 ± 0.24, p = 0.75 for LVEF ≤35% and IC: 1.35 ± 0.44 vs NIC: 1.58 ± 0.50, p = 0.19 for LVEF >35%). However, MPRi was significantly lower in patients with LVEF ≤35% compared with those with LVEF>35% (1.17 ± 0.40 vs 1.47 ± 0.47, p = 0.01). Similar difference between LVEF groups was noted in the patients with NIC (1.15 ± 0.24 vs 1.58 ± 0.50, p = 0.006) but not in the patients with IC (1.20 ± 0.56 vs 1.35 ± 0.44, p = 0.42). MPRi can be abnormal in the presence of left ventricular dysfunction with nonischemic etiology. This is a potential pitfall to consider when using this approach to detect ischemia because of epicardial coronary disease using myocardial perfusion imaging.

摘要

使用血管扩张剂应激心脏磁共振评估心肌灌注储备(MPR)的方法越来越多地用于检测冠状动脉疾病。然而,由于微血管功能的改变,MPR 也可能发生改变。我们旨在确定 MPR 是否可以区分冠状动脉疾病引起的缺血性心肌病(IC)和无潜在心外膜冠状动脉疾病的非缺血性心肌病(NIC)伴微血管功能障碍。总共从现有的血管扩张剂应激心脏磁共振注册中心确定了 60 名患者(平均年龄 65 ± 14 岁,30%为女性),包括 31 名 IC 患者和 29 名 NIC 患者。使用 Simpson 磁盘法在短轴电影片中测量左心室射血分数(LVEF)。使用上升斜率比,在应激和休息期间通过首过心肌灌注图像来确定 MPRi 指数(MPRi),并为动脉输入和心率血压乘积校正进行归一化。在两组患者中,均根据 LVEF 将患者分为 LVEF≤35%和 LVEF>35%亚组。检查了亚组之间 MPRi 的差异。在 NIC 患者中,MPRi 与 LVEF 中度相关(r=0.53,p=0.03),而在 IC 患者中的相关性较低(r=0.32,p=0.22)。NIC 和 IC 中的平均 LVEF 分别为 34%±8%和 35%±8%(p=0.63)。与 NIC 相比,IC 中的 MPRi 没有显著差异(1.17[0.88 至 1.61]与 1.23[1.07 至 1.66],p=0.41),包括 LVEF 亚组(IC:1.20±0.56 与 NIC:1.15±0.24,p=0.75 对于 LVEF≤35%和 IC:1.35±0.44 与 NIC:1.58±0.50,p=0.19 对于 LVEF>35%)。然而,与 LVEF>35%的患者相比,LVEF≤35%的患者 MPRi 明显更低(1.17±0.40 与 1.47±0.47,p=0.01)。在 NIC 患者中也观察到 LVEF 组之间存在类似的差异(1.15±0.24 与 1.58±0.50,p=0.006),但在 IC 患者中则没有(1.20±0.56 与 1.35±0.44,p=0.42)。当使用心肌灌注成像检测心外膜冠状动脉疾病引起的缺血时,非缺血性病因引起的左心室功能障碍时 MPRi 可能异常。这是使用这种方法检测缺血时需要考虑的潜在陷阱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/2439603ac883/nihms-1862547-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/67610272c6b9/nihms-1862547-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/348628783dad/nihms-1862547-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/0644f857efd0/nihms-1862547-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/2439603ac883/nihms-1862547-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/67610272c6b9/nihms-1862547-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/348628783dad/nihms-1862547-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/0644f857efd0/nihms-1862547-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3367/9886436/2439603ac883/nihms-1862547-f0004.jpg